Recurrent Optic Neuritis as the Initial Symptom in Demyelinating Diseases.
10.3988/jcn.2018.14.3.351
- Author:
Alessandra Billi FALCÃO-GONÇALVES
1
;
Denis Bernardi BICHUETTI
;
Enedina Maria Lobato DE OLIVEIRA
Author Information
1. Department of Neurology and Neurosurgery, Federal University of São Paulo (UNIFESP), São Paulo, SP, Brazil. alebfalcao@gmail.com
- Publication Type:Original Article
- Keywords:
optic neuritis;
multiple sclerosis;
neuromyelitis optica;
recurrence;
aquaporin 4
- MeSH:
Antibodies;
Aquaporin 4;
Demyelinating Diseases*;
Diagnosis;
Female;
Follow-Up Studies;
Humans;
Inflammation;
Medical Records;
Multiple Sclerosis;
Myelitis, Transverse;
Neuromyelitis Optica;
Optic Nerve;
Optic Nerve Diseases;
Optic Neuritis*;
Recurrence;
Retrospective Studies;
Visual Acuity
- From:Journal of Clinical Neurology
2018;14(3):351-358
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND AND PURPOSE: Optic neuritis (ON) is an inflammation of the optic nerve that can be recurrent, with unilateral or bilateral presentation. Diagnosing recurrent cases may be challenging. We aimed to compare patients with recurrent ON as their initial symptom according to their following final diagnoses: multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD), or chronic relapsing inflammatory optic neuropathy (CRION). METHODS: The medical records of patients with initial recurrent ON who were followed at the Neuroimmunology Clinic of the Federal University of São Paulo between 2004 and 2016 were analyzed retrospectively. Patients were classified according to their final diagnosis into MS, NMOSD, or CRION, and the characteristics of these groups were compared to identify predictive factors. RESULTS: Thirty-three patients with recurrent ON were included, and 6, 14, and 13 had final diagnoses of MS, NMOSD, and CRION, respectively. Most of the patients were female with unilateral and severe ON in their first episode, and the initial Visual Functional System Score (VFSS) was ≥5 in 63.6%, 85.7%, and 16.7% of the patients with CRION, NMOSD, and MS, respectively. Anti-aquaporin-4 antibodies were detected in 9 of 21 (42.8%) tested patients. Seven of nine (77.8%) seropositive NMOSD patients experienced transverse myelitis episodes during the follow-up period. A multivariate regression analysis showed that the VFSS at the last medical appointment predicted the final diagnosis. CONCLUSIONS: A lower VFSS at the last medical appointment was predictive of MS. Patients with NMOSD and CRION have similar clinical characteristics, whereas NMOSD patients tend to have worse visual acuity.
